The lawyers of Nextons’ Life Sciences practice are known on the pharmaceutical and veterinary markets as practitioners with unique experience in supporting projects in the industry and the day-to-day operations of organizations.

Nextons’ team has vast experience in structuring and supporting venture capital, investment and M&A transactions throughout the life cycle of pharmaceutical and medical companies. Our lawyers have experience working in the industry and an insider’s understanding of the issues. This enables us to successfully support asset deals, which are some of the most complex projects, considering life sciences regulation. It also allows us to handle any projects for our clients, from setting up a company or doing research to launching products on the Russian and foreign markets, creating international consortia and joint ventures or handling IPOs.

Nextons provides comprehensive legal support for pharmaceutical and biotechnology companies, and manufacturers and distributors of medical devices. Our lawyers support clients throughout the complete life cycle of the product: from development, pre-clinical and clinical trials and Market Access, marketing authorization, manufacturing, building a distribution network, promotion and public procurement, up to undergoing Roszdravnadzor audits, interaction with healthcare providers and pharmaceutical professionals, and with patients.

Our team supports complex projects in the pharmaceutical and medical industries to launch new products on the Russian and foreign markets, for manufacturing localization, technology transfer and partnership with the state. With our proficiency in tax and financial planning and network of trusted partners supplying technical and expert solutions, we are able to provide a wide range of services in this area.

Key Service Areas

  • M&A, investment and venture capital transactions
  • Asset due diligence (pharmaceuticals, medical devices, biomedical cell products, manufacturing facilities, healthcare facilities, etc.)
  • Circulation of medical devices
  • Circulation of medicines
  • Market Access
  • Manufacturing and localization
  • Public-private partnerships
  • Digitalization in healthcare

Leave a request

What Our Clients Say

“The firm has a lot of clients in pharma – they have practical examples of how to do this.” Chambers Europe, 2021
“The team manages to navigate us through the constantly changing legislative requirements.”Chambers Europe, 2021
“They can provide the best solutions for different issues.”Chambers Europe, 2020
“The team works with great dedication, they are very hands-on in their approach, and they are a pleasure to deal with. They are really strong in the pharmaceutical field.”The Legal 500, 2020
“They provide detailed answers to any compliance-related questions.”Chambers Europe, 2019